Incyte (INCY): analysis and statistics
Return, volatility, Sharpe ratio and risk for Incyte, an S&P 500 component in the Health Care sector. Data as of 2026-07-30.
| Last close price | $122.94 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | +24.64% |
| Total return over period | +92.94% |
| Annualized volatility | 32.18% |
| Sharpe ratio | 0.65 |
| Sortino ratio | 1.00 |
| Max drawdown | -33.83% |
| CVaR 95% (avg. loss, worst 5% of days) | -4.33% |
| Correlation with the S&P 500 | 0.24 |
| Period range | $51.18 – $129.93 |
| Trading days analyzed | 752 |
Over the last 3.0 years, Incyte (INCY) has posted an annualized return of +24.64% with annual volatility of 32.18%, a Sharpe ratio of 0.65. Its worst stretch (max drawdown from a peak) was -33.83%. Its correlation with the S&P 500 is 0.24, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how INCY would fit inside an optimized portfolio alongside other S&P 500 stocks, try the optimizer.
Optimize a portfolio with INCY →
Other Health Care stocks
What is the Sharpe ratio? · How to optimize an S&P 500 portfolio